[{"Assets_0_Q1_USD":817350000.0,"CommonStockSharesOutstanding_0_Q1_shares":49665203.0,"EarningsPerShareBasic_1_Q1_USD":0.63,"EarningsPerShareDiluted_1_Q1_USD":0.62,"NetIncomeLoss_1_Q1_USD":30253000.0,"StockholdersEquity_0_Q1_USD":723657000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":49077742.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":48190511.0,"Ticker":"RARE","CIK":"1515673","name":"ULTRAGENYX PHARMACEUTICAL INC.","OfficialName":"Ultragenyx Pharmaceutical Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5418950849.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180508"}]